207 related articles for article (PubMed ID: 16844732)
21. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
Taylor R; Morrell S; Mamoon H; Wain G; Ross J
Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
23. Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand.
Priest P; Sadler L; Sykes P; Marshall R; Peters J; Crengle S
Cancer Causes Control; 2010 Feb; 21(2):209-14. PubMed ID: 19847659
[TBL] [Abstract][Full Text] [Related]
24. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
[TBL] [Abstract][Full Text] [Related]
25. The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany.
Siebert U; Sroczynski G; Hillemanns P; Engel J; Stabenow R; Stegmaier C; Voigt K; Gibis B; Hölzel D; Goldie SJ
Eur J Public Health; 2006 Apr; 16(2):185-92. PubMed ID: 16469759
[TBL] [Abstract][Full Text] [Related]
26. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
27. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
Sasagawa T
Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
[TBL] [Abstract][Full Text] [Related]
28. Effect of cervical cancer screening in Scandinavia.
Day NE
Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
[TBL] [Abstract][Full Text] [Related]
29. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer in New Zealand: national and regional trends.
Cox B; Borman B
N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
[TBL] [Abstract][Full Text] [Related]
31. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort.
Suzuki E; Yorifuji T; Takao S; Komatsu H; Sugiyama M; Ohta T; Ishikawa-Takata K; Doi H
Ann Epidemiol; 2009 Oct; 19(10):732-9. PubMed ID: 19628408
[TBL] [Abstract][Full Text] [Related]
32. Body mass index and mortality in women: follow-up of the Canadian National Breast Screening Study cohort.
Jain MG; Miller AB; Rohan TE; Rehm JT; Bondy SJ; Ashley MJ; Cohen JE; Ferrence RG
Int J Obes (Lond); 2005 Jul; 29(7):792-7. PubMed ID: 15809663
[TBL] [Abstract][Full Text] [Related]
33. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
36. Education in relation to incidence of and mortality from cancer and cardiovascular disease in Japan.
Ito S; Takachi R; Inoue M; Kurahashi N; Iwasaki M; Sasazuki S; Iso H; Tsubono Y; Tsugane S;
Eur J Public Health; 2008 Oct; 18(5):466-72. PubMed ID: 18628318
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
38. Cervical cancer in Croatia: state of the art and possibilities for prevention.
Znaor A; Strnad M
Coll Antropol; 2007 Apr; 31 Suppl 2():37-40. PubMed ID: 17598503
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study).
Washio M; Mori M; Khan M; Sakauchi F; Watanabe Y; Ozasa K; Hayashi K; Miki T; Nakao M; Mikami K; Ito Y; Kubo T; Wakai K; Tamakoshi A;
Int J Urol; 2007 May; 14(5):393-7. PubMed ID: 17511719
[TBL] [Abstract][Full Text] [Related]
40. Participation in cervical cancer screening by age and region--a cohort study with a 3 1/2 year follow-up on 2,223,135 women in Bavaria.
Rückinger S; Tauscher M; Redel R; Munte A; Walchner-Bonjean M; Hess J; Schneider A; von Kries R
Gesundheitswesen; 2008 Jun; 70(6):e17-21. PubMed ID: 18661453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
